File Download

There are no files associated with this item.

Supplementary

Conference Paper: Providing information to assist decisions on the inclusion of new vaccines in the childhood immunisation programme in Hong Kong

TitleProviding information to assist decisions on the inclusion of new vaccines in the childhood immunisation programme in Hong Kong
Authors
Issue Date2007
PublisherFood and Health Bureau.
Citation
The 2007 Health Research Symposium, Hong Kong, 29 September 2007, p. 14 How to Cite?
AbstractThere are several vaccines now approved for administration to young children but not yet incorporated into the Hong Kong Childhood Immunisation Programme (CIP). Some of these vaccines are reported as being cost-effective and several are routinely given to infants in other countries. The Scientific Committee on Vaccine Preventable Diseases (Centre for Health Protection, Department of Health) was therefore interested to know the likely cost-effectiveness of some of these vaccines in Hong Kong in order to consider adopting them into the CIP. When translating economic findings from one country to another, it can often be assumed that clinical effects will be similar. However costs, patterns of care and behaviour and baseline prevalence of diseases usually differ. Therefore, it was necessary to model the cost-effectiveness of each vaccine in which the Committee was interested to reflect the local situation. This paper will report on some of the principal challenges and issues in providing useful information to the policy-makers on the cost-effectiveness of these vaccines.
Persistent Identifierhttp://hdl.handle.net/10722/98203

 

DC FieldValueLanguage
dc.contributor.authorMcGhee, SMen_HK
dc.date.accessioned2010-09-25T17:38:50Z-
dc.date.available2010-09-25T17:38:50Z-
dc.date.issued2007en_HK
dc.identifier.citationThe 2007 Health Research Symposium, Hong Kong, 29 September 2007, p. 14en_HK
dc.identifier.urihttp://hdl.handle.net/10722/98203-
dc.description.abstractThere are several vaccines now approved for administration to young children but not yet incorporated into the Hong Kong Childhood Immunisation Programme (CIP). Some of these vaccines are reported as being cost-effective and several are routinely given to infants in other countries. The Scientific Committee on Vaccine Preventable Diseases (Centre for Health Protection, Department of Health) was therefore interested to know the likely cost-effectiveness of some of these vaccines in Hong Kong in order to consider adopting them into the CIP. When translating economic findings from one country to another, it can often be assumed that clinical effects will be similar. However costs, patterns of care and behaviour and baseline prevalence of diseases usually differ. Therefore, it was necessary to model the cost-effectiveness of each vaccine in which the Committee was interested to reflect the local situation. This paper will report on some of the principal challenges and issues in providing useful information to the policy-makers on the cost-effectiveness of these vaccines.-
dc.languageengen_HK
dc.publisherFood and Health Bureau.en_HK
dc.relation.ispartofHealth Research Symposiumen_HK
dc.titleProviding information to assist decisions on the inclusion of new vaccines in the childhood immunisation programme in Hong Kongen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailMcGhee, SM: smmcghee@hkucc.hku.hken_HK
dc.identifier.authorityMcGhee, SM=rp00393en_HK
dc.identifier.hkuros139267en_HK
dc.identifier.spage14en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats